motogen (i.e. causing cell scattering, migration and extracelluHepatocyte growth factor (HGF) is a multifunctional cytolar matrix invasion), morphogen (causing cell polarization and kine which acts as a mitogen, motogen, morphogen and tubulogenesis) and angiogenic factor for a variety of normal angiogenic factor of epithelial cells. HGF receptor is and neoplastic epithelial cells in vitro (9) (10) (11) (12) . In vivo, the encoded by a proto-oncogene, c-met, which is overexpressed HGF-Met pair is essential for embryonic development, tissue in various cancers. The role of HGF and c-Met in prostate regeneration, wound healing and cancer invasion (9, 13, 14) . carcinogenesis, especially in the early stages, is undefined.
Aberrant activation of c-Met, as a result of genetic and In this study, prostatic dysplasia and carcinomas were structural alterations, or changes in the level and pattern induced by testosterone propionate and 17β-estradiol in of expression, confers tumorigenicity and invasiveness to Noble rats. The expression of HGF and c-Met was assessed neoplasms in vitro and in vivo. The c-met protooncogene was at a protein level by immunohistochemistry and western originally identified as an oncogene activated by chromosomal blot analysis. Intense immunostaining for HGFα and rearrangement induced by a chemical carcinogen (15) . The c-Met β-chain was co-localized in dysplastic lesions and in resulting hybrid gene product (Tpr-met) has a constitutively primary and metastatic cancer cells. The levels of HGFα active kinase activity, leading to cell transformation (16). expression were similar among normal control, dysplastic
Familial inherited and spontaneous mutations in c-met are and cancerous prostate tissues, as determined by western responsible for hereditary papillary renal cancer (17). The blot analysis. Immunoblot study for c-Met under reducing mutationally activated c-Met receptor has been shown to conditions identified two bands at 145 kDa (β-subunit of mediate invasive growth and metastasis of cancers (18).
c-Met) and 170 kDa (precursor form of c-Met) in rat liver
Amplification of the c-met gene is a mechanism of c-Met extracts. However, two bands at~220 and 245 kDa were activation in several types of human cancer (19-21) and in a detected in hormone-treated dysplastic prostate tissues and rodent tumor model (22) . Overexpression of the c-Met receptor primary tumors. Overexpression of the 220 kDa band was has been reported in a variety of human malignancies (23-observed in long-term (10-12 months) hormone-treated 25) . Establishment of an autocrine HGF-Met signaling loop prostate and primary tumor extracts. Metastatic tumors in normal cells induces tumorigenesis and the metastatic consistently exhibited up-regulation of a single 245 kDa phenotype (9) . In addition, many reports have demonstrated band. Under non-reducing conditions, however, protein the co-localization of both HGF and c-Met receptors in tumor bands of 220, 280 or 300 kDa were seen in the blots. The cells (26) (27) (28) (29) , suggesting the involvement of autocrine HGFhormone-treated prostate tissues and metastatic tumors Met pathway in carcinogenesis. Structural abnormalities of the expressed the 220 and 300 kDa proteins, respectively. The majority of primary tumors expressed the 280 kDa protein.
c-Met receptor due to post-translational processing defects also In summary, HGF and its receptor, c-Met, were coresult in constitutive activation of the downstream signaling expressed in dysplastic and tumor cells, suggesting that an pathway (30, 31) . autocrine mode of action may be involved in prostate HGF is a paracrine mediator of stromal-epithelial intercarcinogenesis. The close correlation of expression of the actions in the normal prostate, with stromal cells producing high-molecular-weight isoforms of c-Met with different HGF whereas epithelial cells express c-Met receptors (32,33). stages of carcinogenesis implicates that they might play However, Kurimoto et al. (34) have recently shown the codifferential roles in the onset, progression, growth and expression of HGF and c-Met receptor in human prostate metastasis in prostate cancer.
cancer, suggesting the autocrine loop of c-Met activation. Overexpression of the c-Met protein has been observed in malignant prostate tissue (35, 36) . c-Met is preferentially Introduction expressed in androgen-insensitive, metastatic prostate cancer cells such as DU145, PC-3 and MAT-LyLu cell lines (37,38). The c-met proto-oncogene encodes a 190 kDa transmembrane HGF acts to induce mitosis of normal rat prostate epithelial receptor for the hepatocyte growth receptor (HGF) (1, 2) . The cells in vitro (32), anchorage-independent growth of human mature receptor (p190 αβ ) is composed of a 50 kDa α-subunit prostate epithelial cells (39) and proliferation, scattering and and a 145 kDa β-subunit, which are linked by disulfide bonds invasion of DU145 cells (38) . (3, 4) , and is synthesized from a single-chain precursor of
In studying the role of c-Met in prostate cancer, much attention has been put on the late stages of cancer, i.e. invasion in PBS for 15 min at room temperature while no antigen retrieval was needed the role of the HGF-Met signaling system in the onset and for c-Met immunostaining. Sections were then incubated with normal rabbit progression of prostate cancer. In addition, most data are or goat serum for 30 min before overnight incubation at 4°C with the primary available from human tumor samples with heterogeneous antiserum against HGFα (1:150) Biotechnology) for 2 h at room temperature. This competition procedure was the capsules for implantation. Six pieces of 2 cm T capsules and one piece used to validate the specificity of each antibody reagent used for immunoblots. of 1 cm E 2 capsule were surgically implanted subcutaneously on the side of The intensity of the immunoreactive bands were quantified by densitometric the back between the scapula of the rats, under pentobarbitone (Boehringer scanning followed by LabWorks image acquisition and analysis software Ingelheim, Australia) anesthesia. Age-matched control animals were implanted (UVP, Cambridge, UK). with empty capsules. All implants were replaced with new ones every 3 months.
Statistical analysis Tissue sampling procedures
Data are presented as mean Ϯ SEM. The experimental data for statistical Animals were killed by cervical dislocation 0.5, 2, 4, 7, 10 and 12 months significance were analyzed using one-way ANOVA followed by Newmanafter implantation. The entire prostate gland complexes were dissected out Keuls multiple comparison. Comparison between two experimental groups from the rats at autopsy. After removing the anterior and ventral lobes, the was done using unpaired t-tests. dorsolateral lobes were bisected along an axis parallel to the prostatic urethra. One-half was rapidly immersed in 10% buffered formalin and were stepsectioned into two or three slabs (in the same plane as the previous bisection),
Results
which were then oriented during paraffin embedding such that the face closest to the urethra could be sectioned consecutively toward the periphery of
Incidence of hormone-induced prostatic lesions in Noble rats
the gland.
A wide spectrum of pathological lesions in the LP of Noble For tissue protein extractions, the lateral lobe of the prostate (LP) was rats can be induced readily by the combination of T and E 2 excised from the other half of the dorsolateral lobe and further separated into (summarized in Table I ). All of the 35 animals treated two parts, proximal periurethral and distal glandular regions. Our histological analysis showed that in hormone-treated animals the former region mostly with T ϩ E 2 for 7-12 months had developed pre-malignant contains ductal carcinoma masses while the latter part mainly contains dysplastic lesions which were randomly scattered in the glandu- with no evidence of metastasis, and the remaining two exhibited Five micrometer thick sections were cut and stained with hematoxylin and eosin for histopathological examination, using the criteria and classification gross prostatic tumors with macroscopically detectable metaoutlined previously (40) . static lesions found in distant organs. The cumulative incidence The detailed histopathological changes leading from normal followed by a quick rinse in distilled water and phosphate-buffered saline (PBS). Sections for HGFα staining were treated with 0.1% Pronase (Sigma) prostate to fully developed carcinoma have been reported (40, 41) . In this paper, only the points that are directly relevant 7a). In the dysplastic region, both epithelial and smooth muscle cells exhibited strong HGF immunoreactivity (Figure 7b ). The to the present study will be given.
primary and metastatic tumor cells showed moderate to strong Normal prostate. The LP, which has been shown to be the staining for HGF (Figure 7c and d) . No apparent correlation most susceptible lobe of prostate to tumor induction by T ϩ of the level of staining to the grade of prostate adenocarcinoma E 2 (40) , consists of epithelium-lined acini and ducts surrounded was found. However, very weak staining was observed in the by a prominent layer of smooth muscle and interspersed stroma of tumors. fibroblasts ( Figure 1 ). Negative controls. No immunoreaction was observed in control tubules were involved in variable degrees of dysplastic changes, slides when primary antisera were preadsorbed by the respectwhile morphologically unaltered regions were only found ive blocking peptides or replaced with the corresponding occasionally and focally. Thus, the glandular dysplasia isotype normal sera (Figure 7c and 8c, insets). appeared more prevalent in the LP after a much longer period Immunoblot analysis of T ϩ E 2 treatment.
c-Met receptor. c-Met expression was very low or undetectable
HGF. Immunoblots revealed a band at~70 kDa consistent with the expected size of the HGF α-chain ( Figure 9A ). Prostate carcinoma. Most of the fully developed prostate However, densitometric measurement indicated that there was carcinomas detected 7 months after treatment were still small no significant difference in the level of expression among (microscopic) tumors that were localized in the periurethral the normal control and hormone-treated prostate and cancer ductal region of the prostate. All these ductal carcinomas were samples (data not shown). of low grade, i.e. well differentiated (Figure 3 ), but were usually mingled with focal regions of higher grade, i.e.
c-Met expression in reducing SDS-PAGE. The antiserum for moderately/poorly differentiated (Figure 4) . In a small number the β-chain of the c-Met receptor recognized two bands at of animals with long-term T ϩ E 2 treatment (10-12 months), 145 and 170 kDa in the liver extracts from adult or neonatal macroscopically gross tumors in the prostate (figure not shown) rats at the reducing condition ( Figure 9B ). The 145 and and distinct metastases to various organs such as, lung, liver, 170 kDa bands correspond to the mature β-chain and the wall of gastrointestinal tract and peritoneum, were also found precursor of c-Met, respectively. No band was detected in (Figure 5 ). Within a metastatic lesion, anaplastic tumor cells the normal prostate extracts whereas all the prostate samples aggregated to form isolated islands, chords or trabeculae which from the groups implanted T ϩ E 2 either short-term (for were interspersed with surrounding fibroblastic stromal cells 2-4 months) or long-term (for 10-12 months) expressed the ( Figure 6) . 220 kDa band. However, the 245 kDa band was only Immunohistochemistry detected in four (66.7%) of six and one (11%) of nine prostate tissues treated with T ϩ E 2 for 2-4 and 10-12 HGF. For the normal control prostate, intense immunostaining for HGF was primarily located in the smooth muscle cells; months, respectively. The 220 or 245 kDa proteins, or both of them, were detected in the primary tumor extracts while weak staining was occasionally seen in the epithelium (Figure only the 245 kDa band was found in the metastatic tumor (P Ͻ 0.05). The primary tumor extracts also expressed more of the 220 kDa band than the long-term treatment samples. Densitometric measurements (Figure 10 ) revealed that there was a significant increase in the expression of group. Expression of the 245 kDa protein was significantly (~6-fold) higher in the metastatic prostate tumors than in 220 kDa band in the prostate tissues after long-term (10-12 months) T ϩ E 2 implantation, when compared the primary tumors and hormone-treated prostate tissues (P Ͻ 0.01). with those after the short-term (2-4 months) treatment c-Met expression in non-reducing SDS-PAGE. Three protein immunoblot analysis clearly indicated that overexpression of bands, of 220, 280 and 300 kDa, were seen under non-reducing high-molecular-weight isoforms of c-Met was correlated with conditions ( Figure 9C ). The metastatic tumor extracts only different stages of prostatic carcinogenesis, suggesting that expressed the 300 kDa protein whereas the T ϩ E 2 -treated these aberrant isoforms may play different roles in the developprostate extracts only expressed the 220 kDa protein. Heteroment of prostate cancers in the Noble rat. geneous expression of all three native protein bands was found
To evaluate the specificity of the immunohistochemistry in the primary tumor samples, with the majority (75%) and western blot, negative controls were performed by preexpressing the 280 kDa band (Table I) .
adsorption of primary antisera with an excess of the respective blocking peptide antigens or by replacement of primary antisera Negative controls. All bands in the blots completely disapwith normal sera of the corresponding isotype. Immunostaining peared when the primary antisera were incubated with the in the control slides or bands in the control blots was completely corresponding blocking peptides before blotting (Figure 9: abolished. Since our primary antiserum for the β-chain of panel A, lane 5; panel B, lane 9; panel C, lane 5).
c-Met detected bands that differed from the reported size of c-Met β-chain (145 kDa), liver extracts from the adult or Discussion neonatal rat were prepared to test the validity of the antibody. In the present study, we modified the hormone regimen that These positive control extracts exhibited two bands at 145 kDa was previously established by our laboratory (40, 41) by and 170 kDa, which corresponded to the β-subunit and the increasing the dosage of testosterone from~175 mg to~210 mg, precursor of c-Met, respectively. while keeping the amount of estrogen (~25 mg) unchanged.
In line with previous studies (32,33), immunostaining for With this modified protocol, our current animal model has HGF was mainly located in the smooth muscle layers of achieved what earlier models (40, (42) (43) (44) (45) failed to do. All normal prostate. The mild positivity of HGF in the epithelium animals receiving prolonged treatment (10-12 months) with may be due to the diffusion of this soluble factor from its T ϩ E 2 developed not only microscopic prostate tumors, but stromal source. The c-Met protein was barely detectable in also grossly visible prostate tumors (organ-confined) and the normal prostate by immunohistochemistry and western macroscopically detectable metastatic lesions, which are more blot. In normal human prostate, c-Met was found in the basal clinically relevant to human prostate carcinogenesis.
epithelial cells but not in the luminal epithelial cells. A more We have demonstrated that, in this system, pre-malignant sensitive method, using reverse transciption-polymerase chain dysplastic lesions were found scattered in the glandular region reaction (RT-PCR), has demonstrated the presence of c-met of the prostate and appeared more prevalent with longer period transcripts in isolated prostate epithelial cells which showed a of hormonal treatment. However, fully developed tumors mitogenic response to the exogenous HGF (32). This observa-(microscopic in nature) were mainly localized in the periurtion suggests that c-Met protein is expressed by normal prostate ethral area of the prostate, suggesting that the proximal ducts epithelial cells at a very low level. HGF fulfils the requirement of LP are more susceptible to hormonal carcinogenesis (44) .
as a paracrine mediator in stromal-epithelial interactions, but The peculiar feature of the current model in anatomical such interactions may be arrested in the normal adult prostate. localizations of pathological lesions enables us easily to isolate Intense immunostaining for HGF was detected in both the dysplastic tissues (in distal glandular regions) from the epithelial and smooth muscle cells in the dysplastic regions. cancerous masses (in proximal ductal regions) in hormoneIn primary and metastatic tumors, HGF immunoreactivity was treated LP. Although morphologically unaltered epithelia were primarily found in the carcinoma cells, but not in the stromal found to co-exist with dysplastic lesions even in the LP gland component. Based on this observation, it is likely that the after long-term (10-12 month) hormonal treatment, these expression of HGF may be switched from the stroma to the apparently 'normal' regions displayed distinctive nuclear epithelium during the course of hormone-induced prostate abnormalities resembling typical dysplasia, as assessed by carcinogenesis. In situ hybridization studies are needed to electron microscopy (unpublished observation). Thus it is confirm the site of synthesis of HGF. Co-localization of HGF believed that almost all the prostatic epithelial cells, particularly and c-Met proteins in dysplastic and cancer cells raises the after long-term treatment with T ϩ E 2 , exhibited variable possibility that autocrine mechanism may be exercised in the degrees of dysplastic changes. The advantages of the present development of prostate cancers. A previous study (48) has animal model, should facilitate our study of the underlying shown that the c-Met protein was frequently detected in mechanisms of prostate carcinogenesis, which is still poorly dysplastic cells in human prostatic intraepithelial neoplasia; understood.
the expression of HGF was not documented. Autocrine HGFThe role of HGF and its receptor, c-Met, in metastasis and Met signaling has been reported in a variety of human invasion of prostate cancer has been well established. There malignancies, including prostate, breast and lung cancers is a close correlation between c-Met expression and increased (34, 46, 47) . The induction of sarcoma by co-transfection of grade of human prostate cancers (37,45). The c-Met receptor HGF and c-met genes into mesenchymal cells (48) supports is preferentially expressed in androgen-insensitive, highly the autocrine pathway in carcinogenesis. metastatic prostate cancer cell lines. In vitro studies provided Although HGF appeared to be ectopically expressed in direct evidence that HGF induces proliferation and scattering prostate cancer cells, no apparent increase in the level of HGF of prostate cancer cells and increases their invasive potential expression was found in prostate tumors, as demonstrated in (37,38). However, the role of HGF and c-Met receptor, other our immunoblot analysis. Tsuka et al. (49) have shown higher than in invasion and metastasis, in prostate cancer remains expression of HGF protein in non-malignant human prostate poorly defined.
samples than prostate cancers. No overexpression of HGF was We have demonstrated the co-expression of HGF and c-Met found in a chemical-induced rat sarcoma displaying c-met receptor in dysplasia (a pre-malignant lesion), localized and metastatic prostate cancers induced in our model system. Our gene amplification and overexpression (22). In contrast, over-expression of HGF has been reported in bladder carcinomas of the p245 isoform appeared to be correlated with the metastatic capability of tumors. There was a striking increase (50) .
Our immunoblot studies probed with the c-Met β-chain-(~6-fold) in p245 expression in metastatic tumors when compared with the primary tumors. In contrast, the p220 isoform specific antiserum showed overexpression of bands at 220 and 245 kDa, also termed p220 and p245, respectively, in the was not detected in metastatic tumor extracts and a high level of p220 expression was observed in primary tumors and hormone-treated prostate and the induced cancers. At present we can only speculate on the biological significance of these prostate tissues after long-term (10-12 months) treatment with hormones. The pattern of expression of p220 and p245 suggests high-molecular-weight β-chain isoforms of c-Met. Expression that these two isoforms may play different roles in the β-chain of the c-Met receptor (145 kDa). The size difference may be attributed to different post-translational glycosylations, development of prostate cancers. p220 may be more important in the early phase of prostatic carcinogenesis, i.e. initiation gene mutations or rearrangement, alternative splicing, or defective post-translational processing (15) (16) (17) (18) 30, 31) . To and progression, while p245 may play a particular role in the invasive growth of prostate cancers.
investigate whether the p220 and p245 β-chain isoforms would form a heterodimer with the corresponding α-chain, western The p220 and p245 isoforms recognized in a reducing SDSpolyacrylamide gel differ in molecular size from the reported blots were performed under non-reducing conditions. Three protein bands, of 220, 280 and 300 kDa, were detected.
Comparison with the profile of c-Met expression under reducing conditions suggested that the two larger (280 and 300 kDa) proteins appeared to be composed of the aberrant β-chain (p220 or p245) and an α-chain (of~50 kDa) linked by disulfide bridges. However, a single strong band was detected at 220 kDa under non-reducing conditions in all four prostate tissues with T ϩ E 2 treatment and in two (25%) of eight primary prostate cancers, showing that p220 may also exist as a monomeric protein. Overall, our observations raise the possibility that there might be two co-existent species of p220, one forms a 280 kDa complex with other subunits, possibly the α-subunits, while the other does not. It seems that p245 may preferentially bind with other subunits, possibly the α-subunit, forming the dimeric c-Met isoform of~300 kDa. Further studies are required to characterize the molecular nature of these isoforms and to verify whether they are functional or not.
Multiple mechanisms for generating the aberrant c-Met isoforms may be involved in prostatic carcinogenesis in our model. Different mechanisms have been proposed for the generation of aberrant c-Met receptor isoforms. Defective post- 
